Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.
Neurology
; 68(10): 757-63, 2007 Mar 06.
Article
in En
| MEDLINE
| ID: mdl-17339583
ABSTRACT
OBJECTIVE:
Mild cognitive impairment, hypothesized to be prodromal Alzheimer disease (AD), shows abundant senile plaques and neurofibrillary tangles, but its biochemical correlates remain undefined.METHODS:
Biochemical profiles of Abeta, tau, alpha-synuclein, and oxidative pathologies were characterized in middle frontal gyrus, inferior parietal cortex, and entorhinal cortex in postmortem frozen brains from subjects diagnosed antemortem with no cognitive impairment, mild cognitive impairment, or AD.RESULTS:
Insoluble Abeta and tau, as well as tissue isoprostanes, from each brain region analyzed did not correlate with the clinical diagnosis proximate to death, but insoluble Abeta and 8,12-iso-iPF(2alpha)-VI levels from gray matter of all brain regions correlated strongly with the burden of AD pathology, whereas insoluble tau did not.CONCLUSIONS:
The biochemical alterations in cortical tau, Abeta, and isoprostane do not reflect the onset of clinical dementia.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Chemistry
/
Cerebral Cortex
/
Cognition Disorders
/
Alzheimer Disease
Type of study:
Diagnostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Neurology
Year:
2007
Document type:
Article
Affiliation country:
United States